Public-registry site landscape for NCT06828848, a Gram Negative Infections study sponsored by Menarini Group. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT06828848 (registry record) |
| Sponsor | Menarini Group |
| Condition(s) | Gram Negative Infections |
| Phase | PHASE2 |
| Listed sites | 22 |
| Site countries | Czechia, France, Italy, Poland, Spain |
Eichor generates a preliminary site-risk snapshot for NCT06828848 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →